Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Ugeskrift for Laeger|April 16, 2026
[Lumboperitoneal shunts in hydrocephalus]Adrian Pradel, Frantz Rom Poulsen, Mathias Just Nortvig, et al.Journal of Integrative Neuroscience|March 28, 2025
Peripheral Nervous System Complications after COVID-19 VaccinationSeyed Sepehr Khatami, Samaneh Ghorbani Shirkouhi, Poul Flemming Høilund-Carlsen, et al.Journal of Neuroscience Research|May 2, 2007
Expansion and characterization of ventral mesencephalic precursor cells: effect of mitogens and investigation of FA1 as a potential dopaminergic markerPia Jensen, Matthias Bauer, Charlotte H Jensen, et al.Behavioural Brain Research|January 2, 2022
Impact of MRI on decision-making in ICU patients with disorders of consciousnessSimon S Albrechtsen, Robert G C Riis, Moshgan Amiri, et al.Neurology|May 26, 2019
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson diseaseFranziska Hopfner, Mette Wod, Günter U Höglinger, et al.Ugeskrift for Laeger|November 18, 2015
[Workup and treatment of autoimmune encephalitis]Morten Blaabjerg, Camilla C Mærsk-Møller, Daniel Kondziella, et al.Cells|April 30, 2021
Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human NeuronsMatias Ryding, Mattias Gamre, Mette S Nissen, et al.Ideggyogyaszati Szemle|February 22, 2018
Four cases of GABAB receptor encephalitisMónika Szőts, Morten Blaabjerg, Daniel Kondziella, et al.Journal of Neurochemistry|March 1, 2017
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesiaAndreas Dammann Andersen, Morten Blaabjerg, Michael Binzer, et al.Current Drug Targets. CNS and Neurological Disorders|August 17, 2005
Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepairJens Noraberg, Frantz Rom Poulsen, Morten Blaabjerg, et al.Pageof 9